Concentrations of N-(phosphonacetyl)-L-aspartate (PALA) in plasma and tears in man.
作者信息
Lankelma J, Penders P G, Leyva A, Kleeberg U R, Kenny J B, Bramwell V, McVie J G, Pinedo H M
出版信息
Eur J Cancer Clin Oncol. 1981 Nov;17(11):1199-204.
PMID:7199467
Abstract
摘要
相似文献
1
Concentrations of N-(phosphonacetyl)-L-aspartate (PALA) in plasma and tears in man.
Eur J Cancer Clin Oncol. 1981 Nov;17(11):1199-204.
2
Penetration of N-(phosphonacetyl)-L-aspartate into human central nervous system and intracerebral tumor.
Cancer Res. 1980 Sep;40(9):3163-6.
3
Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung.
Cancer Treat Rep. 1980 Apr-May;64(4-5):705-7.
4
Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA).
Cancer Treat Rep. 1980 Feb-Mar;64(2-3):285-92.
5
6
Application of a simple competitive protein-binding assay technique to the pharmacokinetics of N-(phosphonacetyl)-L-aspartate in humans.
Cancer Res. 1980 Jun;40(6):1902-6.
7
Cooperative binding of the bisubstrate analog N-(phosphonacetyl)-L-aspartate to aspartate transcarbamoylase and the heterotropic effects of ATP and CTP.
J Biol Chem. 1989 Feb 15;264(5):2476-81.
8
Role of endocytosis and lysosomal pH in uptake of N-(phosphonacetyl)-L-aspartate and its inhibition of pyrimidine synthesis.
Cancer Res. 1984 Feb;44(2):507-13.
9
Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activity.
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):967-73.
10
Long-term association of N-(phosphonacetyl)-L-aspartate with bone.
Cancer Res. 1981 Jan;41(1):150-6.
Zotero 插件